Ticagrelor Krka 90 mg filmomhulde tabletten
As listed in the register: Ticagrelor Krka 90 mg filmomhulde tabletten
90 mg · filmomhulde tablet
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Ticagrelor
- Used in
- Blood, clotting and anaemia
- Made by
- Krka d.d., Novo mesto
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (ticagrelor). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Ticagrelor and its major metabolite reversibly interact with the platelet P2Y 12 ADP-receptor to prevent signal transduction and platelet activation.
Ticagrelor and its active metabolite are approximately equipotent.
Ticagrelor can be taken with or without food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-27
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (ticagrelor). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: BLEEDING RISK Ticagrelor, like other antiplatelet agents, can cause significant, sometimes fatal bleeding ( 5.1, 6.1 ).
- History of intracranial hemorrhage.
- ( 4.1 ) Active pathological bleeding.
- ( 4.2 ) Hypersensitivity to ticagrelor or any component of the product.
Most common adverse reactions (>5%) are bleeding and dyspnea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States32 matching products
Bulgaria16 matching products
- Ticasa Ticasa 90 mg · film - coated tablets2 makers
- Atixarso 90 mg · film - coated tablets
- KOGAVANT 90 mg · film - coated tablets
- Krusaxyl 90 mg · film - coated tablets
- Lacrat 90 mg · film-coated tablets
- Orebriton 90 mg · film - coated tablets
- Plategra 90 mg · film - coated tablets
- Polsar 90 mg · film - coated tablets
European UnionNo exact match for this strength and form
Spain33 matching products
- BRILIQUE 90 mg · comprimido bucodispersable3 makers
- LACRAT 90 mg · comprimido recubierto con película
- TICAGRELOR ABDI 90 mg · comprimido recubierto con película
- TICAGRELOR ALTER 90 mg · comprimido recubierto con película
- TICAGRELOR ARISTO 90 mg · comprimido recubierto con película
- TICAGRELOR AUROVITAS 90 mg · comprimido recubierto con película
- TICAGRELOR BLUEFISH 90 mg · comprimido recubierto con película
- TICAGRELOR CINFA 90 mg · comprimido recubierto con película
Canada7 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Krka d.d., Novo mesto |
|---|---|
| Active substance | Ticagrelor |
| Used in | Blood, clotting and anaemia |
| Strength | 90 mg |
| Form | filmomhulde tablet |
| Classification | B01AC24 · Blood, clotting and anaemia |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| RVG | 126132 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.